MediciNova (MNOV) Competitor Comparison
We are evaluating the key criteria listed to compare MediciNova (MNOV) against its competitors in the Biotechnology industry.
Market Capitalization
285 / 368Gross Profits
0 / 278Total Revenue
236 / 300EBITDA
60 / 337Free Cashflow
82 / 352Quick Ratio
30 / 357Earnings per Share
53 / 359Dividend yield
0 / 6Total Cash
256 / 358Performance 3 years
182 / 368Performance 5 years
236 / 368Performance 10 years
154 / 368Linearity 3 years
109 / 368Linearity 5 years
207 / 368Linearity 10 years
41 / 368Total Rank
192 / 368Dividend Rank
198 / 368Valuation Rank
151 / 368Piotroski Rank
96 / 368Muliplier Rank
152 / 368Total Cash - MNOV ranking 256 / 358
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.